These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29759554)

  • 1. The identification and isolation of CTCs: A biological Rubik's cube.
    Mansilla C; Soria E; Ramírez N
    Crit Rev Oncol Hematol; 2018 Jun; 126():129-134. PubMed ID: 29759554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size-based separation methods of circulating tumor cells.
    Hao SJ; Wan Y; Xia YQ; Zou X; Zheng SY
    Adv Drug Deliv Rev; 2018 Feb; 125():3-20. PubMed ID: 29326054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour cell isolation, analysis and clinical application.
    Zhang X; Xie P; Zhang K; Zhang W
    Cell Oncol (Dordr); 2023 Jun; 46(3):533-544. PubMed ID: 36658417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis.
    PramaniK A; Jones S; Gao Y; Sweet C; Vangara A; Begum S; Ray PC
    Adv Drug Deliv Rev; 2018 Feb; 125():21-35. PubMed ID: 29329995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?
    Murlidhar V; Rivera-Báez L; Nagrath S
    Small; 2016 Sep; 12(33):4450-63. PubMed ID: 27436104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype.
    Wang H; Wu X
    Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical applications.
    Pei H; Li L; Han Z; Wang Y; Tang B
    Lab Chip; 2020 Nov; 20(21):3854-3875. PubMed ID: 33107879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cell isolation, culture, and downstream molecular analysis.
    Sharma S; Zhuang R; Long M; Pavlovic M; Kang Y; Ilyas A; Asghar W
    Biotechnol Adv; 2018; 36(4):1063-1078. PubMed ID: 29559380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells: evolving evidence and future challenges.
    Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
    Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials.
    Bünger S; Zimmermann M; Habermann JK
    Cancer Metastasis Rev; 2015 Sep; 34(3):527-45. PubMed ID: 26323491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform.
    Sollier-Christen E; Renier C; Kaplan T; Kfir E; Crouse SC
    Cytometry A; 2018 Dec; 93(12):1240-1245. PubMed ID: 30211979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic technologies for circulating tumor cell isolation.
    Cho H; Kim J; Song H; Sohn KY; Jeon M; Han KH
    Analyst; 2018 Jun; 143(13):2936-2970. PubMed ID: 29796523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells.
    Shi J; Zhao C; Shen M; Chen Z; Liu J; Zhang S; Zhang Z
    Biosens Bioelectron; 2022 Apr; 202():114025. PubMed ID: 35078145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
    Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L
    Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.